In U.S., GLP-1 Usage Reaches New HighJULY 7, 2026#weight-loss#semaglutide#tirzepatide#Compounding#glp1-agonist#backfilled·news.gallup.com·Jul 7, 2026In U.S., GLP-1 Usage Reaches New High
UK unable to tackle weight-loss drug black market, MP warns | The IndependentJuly 3, 2026#MHRA#counterfeit-drugs#weight-loss#Ozempic#glp1-agonist#United-Kingdom#backfilled·independent.co.uk·Jul 6, 2026UK unable to tackle weight-loss drug black market, MP warns | The Independent
Dutch hospitals issue warning after fake weight-loss drugs cause comas | NL TimesJuly 1, 2026#Netherlands#weight-loss#unapproved-drugs#semaglutide#Insulin#glp1-agonist#backfilled·nltimes.nl·Jul 2, 2026Dutch hospitals issue warning after fake weight-loss drugs cause comas | NL Times
‘Grave allegations’: Gurgaon court denies bail to fake Mounjaro racket mastermind | Delhi News - The Indian ExpressJune 27, 2026#India#counterfeit-injections#Mounjaro#glp1-agonist#backfilled·indianexpress.com·Jun 29, 2026‘Grave allegations’: Gurgaon court denies bail to fake Mounjaro racket mastermind | Delhi News - The Indian Express
Are People With Eating Disorders Misusing GLP-1 Drugs? | MedPage TodayJune 24, 2026#glp1-agonist#eating-disorders#not-for-the-roundup#backfilled·medpagetoday.com·Jun 26, 2026Are People With Eating Disorders Misusing GLP-1 Drugs? | MedPage Today
GLP-1 reimbursement crisis: What independent pharmacies need to know about staying viable | Pharmacy TimesJune 25, 2026#GoodRx#glp1-agonist#independent-pharmacies#not-for-the-roundup#backfilled·pharmacytimes.com·Jun 26, 2026GLP-1 reimbursement crisis: What independent pharmacies need to know about staying viable | Pharmacy Times
Record retatrutide haul found in illegal pharmacy laboratory | eKathimerini.comJune 22, 2026#retatrutide#Greece#Eli-Lilly#tirzepatide#weight-loss#glp1-agonist#backfilled·ekathimerini.com·Jun 25, 2026Record retatrutide haul found in illegal pharmacy laboratory | eKathimerini.com
Warning on promoting newly licensed prescription-only medicines and unlicensed medicines for weight management - GOV.UKJune 18, 2026#MHRA#glp1-agonist#injectables#weight-loss#United-Kingdom#backfilled·gov.uk·Jun 18, 2026Warning on promoting newly licensed prescription-only medicines and unlicensed medicines for weight management - GOV.UK
FDA steps up crackdown on compounded GLP-1s - EMJ GOLDJune 11, 2026#Shabbir-quote#Compounding#glp1-agonist#backfilled·emjreviews.com·Jun 12, 2026FDA steps up crackdown on compounded GLP-1s - EMJ GOLD
The warning doctors want every Ozempic, Wegovy and Mounjaro user to hear about fake versionsJune 6, 2026#glp1-agonist#Ozempic#Wegovy#Mounjaro#backfilled·msn.com·Jun 8, 2026The warning doctors want every Ozempic, Wegovy and Mounjaro user to hear about fake versions
Fake Ozempic: How batch numbers help criminal groups spread dangerous weight loss drugsSeptember 5, 2024#counterfeit-injections#glp1-agonist#Ozempic#board-quote#Mexican-pharmacy#Mx-pharmacy-page#backfilled·reuters.com·Sep 5, 2024Fake Ozempic: How batch numbers help criminal groups spread dangerous weight loss drugs
Generic semaglutide race hinges on API supply as China leads: Goldman Sachs - The HinduBusinessLineJune 07, 2026#semaglutide#generic-drugs#industry#not-for-the-roundup#glp1-agonist#backfilled·thehindubusinessline.com·Jun 8, 2026Generic semaglutide race hinges on API supply as China leads: Goldman Sachs - The HinduBusinessLine
Eli Lilly wins argument over Noom’s GLP-1 dosing claimsMay 27, 2026#Eli-Lilly#glp1-agonist#backfilled·fiercepharma.com·Jun 1, 2026Eli Lilly wins argument over Noom’s GLP-1 dosing claims
Hims & Hers launches generic semaglutide offering in Canada | MobiHealthNewsMay 22, 2026#Hims&Hers#semaglutide#Canada#glp1-agonist#backfilled·mobihealthnews.com·May 22, 2026Hims & Hers launches generic semaglutide offering in Canada | MobiHealthNews
Harbin Jixianglong Biotech Co., Ltd. - 723330 - 05/01/2026 | FDAMay 1, 2026#FDA#Warning-letters#CGMP-violations#semaglutide#APIs#glp1-agonist#backfilled·fda.gov·May 20, 2026Harbin Jixianglong Biotech Co., Ltd. - 723330 - 05/01/2026 | FDA
ProRx LLC - 723704 - 04/07/2026 | FDAApril 7, 2026#FDA#Warning-letters#503B#Compounding#Pennsylvania#sterility-issues#tirzepatide#semaglutide#glp1-agonist#backfilled·fda.gov·May 13, 2026ProRx LLC - 723704 - 04/07/2026 | FDA
Attorney General Tong announces online platform to cease bootleg weight loss drug salesMay 6, 2026#Connecticut#glp1-agonist#weight-loss#made-in-China#backfilled·portal.ct.gov·May 8, 2026Attorney General Tong announces online platform to cease bootleg weight loss drug sales
FDA proposes to exclude semaglutide, tirzepatide, and liraglutide on 503B Bulks List | FDAApril 30, 2026#FDA#503B#Compounding#glp1-agonist#backfilled·fda.gov·May 4, 2026FDA proposes to exclude semaglutide, tirzepatide, and liraglutide on 503B Bulks List | FDA
FDA intensifies crackdown on GLP-1 compounding | MedPage TodayApril 30, 2026#glp1-agonist#fda#Compounding#backfilled·medpagetoday.com·May 1, 2026FDA intensifies crackdown on GLP-1 compounding | MedPage Today
Fake Mounjaro row: Accused had his own brand, 'Toneup' | Gurgaon News - The Times of IndiaApr 26, 2026#India#counterfeit-injections#Mounjaro#tirzepatide#glp1-agonist#backfilled·timesofindia.indiatimes.com·Apr 27, 2026Fake Mounjaro row: Accused had his own brand, 'Toneup' | Gurgaon News - The Times of India
Telangana: 75 medical shops found violating norms on weight-loss drugsApril 24, 2026#Mounjaro#Ozempic#Wegovy#Rybelsus#India#glp1-agonist#backfilled·thesouthfirst.com·Apr 24, 2026Telangana: 75 medical shops found violating norms on weight-loss drugs
Blurred packaging, wrong colours, water mixed with drugs: Inside Gurugram's fake Mounjaro racketApril 23, 2026#India#counterfeit-drugs#Mounjaro#glp1-agonist#backfilled·moneycontrol.com·Apr 23, 2026Blurred packaging, wrong colours, water mixed with drugs: Inside Gurugram's fake Mounjaro racket
‘Secret shopper’ study finds risks in compounded GLP-1sApril 20, 2026#glp1-agonist#Compounding#backfilled·medscape.com·Apr 21, 2026‘Secret shopper’ study finds risks in compounded GLP-1s
Doctor gets probation for selling weightloss drugs from China to hospital colleagues - Mon Valley IndependentApril 17, 2026#Pennsylvania#glp1-agonist#China#imported-drugs#misbranded-drugs#tirzepatide#weight-loss#backfilled·monvalleyindependent.com·Apr 20, 2026Doctor gets probation for selling weightloss drugs from China to hospital colleagues - Mon Valley Independent
Lilly backs regulatory action after fake Mounjaro seizure in Gurugram | Company News - Business StandardApril 20, 2026#India#counterfeit-injections#Mounjaro#glp1-agonist#backfilled·business-standard.com·Apr 20, 2026Lilly backs regulatory action after fake Mounjaro seizure in Gurugram | Company News - Business Standard
Inside India’s rising counterfeit drug market as fake Mounjaro bust exposes system gaps - The Logical IndianApril 20, 2026#India#counterfeit-injections#glp1-agonist#Mounjaro#backfilled·thelogicalindian.com·Apr 20, 2026Inside India’s rising counterfeit drug market as fake Mounjaro bust exposes system gaps - The Logical Indian
Generic semaglutide fuels UK grey market, expert warns - Pharmacy BusinessApril 18, 2026#semaglutide#generic-drugs#black-market#United-Kingdom#glp1-agonist#backfilled·pharmacy.biz·Apr 20, 2026Generic semaglutide fuels UK grey market, expert warns - Pharmacy Business
Lawsuit claims GLP-1 diet drug killed Texas woman | king5.comApril 14, 2026#Texas#Compounding#glp1-agonist#Empower#weight-loss#backfilled·king5.com·Apr 17, 2026Lawsuit claims GLP-1 diet drug killed Texas woman | king5.com
Pharmacists want action on fake weight-loss jabsApril 15, 2026#United-Kingdom#counterfeit-injections#glp1-agonist#weight-loss#backfilled·bbc.com·Apr 17, 2026Pharmacists want action on fake weight-loss jabs
Man hospitalized after taking unapproved weight-loss drug - Men's JournalApril 17, 2026#retatrutide#South-Carolina#poisoning#glp1-agonist#weight-loss#backfilled·mensjournal.com·Apr 17, 2026Man hospitalized after taking unapproved weight-loss drug - Men's Journal